Free Trial
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free MET Stock Alerts

MetLife (MET) Financials

MetLife logo
$80.22 +0.33 (+0.41%)
Closing price 03:59 PM Eastern
Extended Trading
$80.95 +0.73 (+0.90%)
As of 04:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for MetLife

Annual Income Statements for MetLife

This table shows MetLife's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 5,215 747 3,907 4,982 5,721 5,191 6,654 5,099 1,380 4,226 3,173
Consolidated Net Income / (Loss)		 5,385 854 4,020 5,128 5,909 5,418 6,876 5,302 1,602 4,444 3,403
Net Income / (Loss) Continuing Operations		 4,061 3,588 5,006 5,128 5,909 5,418 6,876 5,302 1,602 4,444 3,403
Total Pre-Tax Income 		5,651 4,281 3,536 6,307 6,795 6,927 8,518 6,364 2,162 5,622 4,661
Total Revenue		 61,343 60,787 62,308 67,941 69,620 67,842 68,696 72,444 67,899 70,986 77,592
Net Interest Income / (Expense)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income		 61,343 60,787 62,308 67,941 69,620 67,842 68,696 72,444 67,899 70,986 77,592
Other Service Charges		 7,497 7,168 6,851 7,382 7,445 7,452 7,863 7,855 7,678 7,575 7,830
Net Realized & Unrealized Capital Gains on Investments		 17,443 16,417 16,465 16,719 19,940 18,356 19,681 12,405 14,944 18,466 19,475
Premiums Earned		 36,403 37,202 38,992 43,840 42,235 42,034 41,152 48,510 44,283 44,945 49,779
Other Non-Interest Income		 - - - - - - - 3,674 994 - 508
Total Non-Interest Expense		 55,692 56,506 58,772 61,634 62,825 60,915 60,178 66,080 65,737 65,364 72,931
Property & Liability Insurance Claims		 39,559 41,534 43,920 46,669 47,925 46,675 48,517 53,401 52,450 52,861 58,668
Insurance Policy Acquisition Costs		 1,356 1,223 1,231 1,251 1,211 1,090 880 706 622 595 553
Other Operating Expenses		 14,777 13,749 13,621 13,714 13,689 13,150 12,018 11,973 12,665 13,017 13,710
Income Tax Expense		 1,590 693 -1,470 1,179 886 1,509 1,642 1,062 560 1,178 1,258
Preferred Stock Dividends Declared		 158 103 103 141 178 216 201 185 198 200 206
Net Income / (Loss) Attributable to Noncontrolling Interest		 12 4.00 10 5.00 10 11 21 18 24 18 24
Basic Earnings per Share		 $4.67 $0.68 $3.65 $4.95 $6.10 $5.72 $7.71 $6.35 $1.82 $5.98 $4.74
Weighted Average Basic Shares Outstanding		 1.12B 1.10B 1.07B 1.01B 915.83M 884.40M 825.08M 774.36M 723.02M 681.23M 652.05M
Diluted Earnings per Share		 $4.62 $0.67 $3.62 $4.91 $6.06 $5.68 $7.65 $6.30 $1.81 $5.94 $4.71
Weighted Average Diluted Shares Outstanding		 1.12B 1.10B 1.07B 1.01B 915.83M 884.40M 825.08M 774.36M 723.02M 681.23M 652.05M
Weighted Average Basic & Diluted Shares Outstanding		 1.12B 1.10B 1.07B 1.01B 915.83M 884.40M 825.08M 774.36M 723.02M 681.23M 652.05M
Cash Dividends to Common per Share		 $1.48 $1.58 $1.60 $1.66 $1.74 $1.82 $1.90 $1.98 $2.06 $2.16 $2.25

Quarterly Income Statements for MetLife

This table shows MetLife's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 370 422 574 800 912 1,275 1,239 879 698 818 778
Consolidated Net Income / (Loss)		 408 495 614 875 953 1,341 1,275 950 735 902 816
Net Income / (Loss) Continuing Operations		 408 495 614 875 953 1,341 1,275 950 735 902 816
Total Pre-Tax Income 		430 534 941 1,045 1,202 1,994 1,381 1,354 980 1,210 1,117
Total Revenue		 16,623 15,866 20,210 16,751 17,823 17,909 19,612 18,569 17,617 17,361 24,045
Total Non-Interest Income		 16,623 15,866 20,210 16,751 17,823 17,909 19,612 18,569 17,617 17,361 24,045
Other Service Charges		 1,909 1,940 1,901 1,922 1,919 1,876 1,858 1,916 1,938 1,971 2,005
Net Realized & Unrealized Capital Gains on Investments		 3,036 2,696 5,341 4,082 4,276 5,917 4,191 4,930 4,592 4,835 5,118
Premiums Earned		 11,678 11,230 11,786 10,053 11,628 10,647 12,617 11,723 10,810 10,555 16,691
Total Non-Interest Expense		 16,193 15,332 19,269 15,706 16,621 15,915 18,231 17,215 16,637 16,151 22,928
Property & Liability Insurance Claims		 13,726 12,771 14,217 12,364 13,475 12,634 14,594 13,422 13,167 12,771 19,308
Insurance Policy Acquisition Costs		 151 153 159 147 148 150 150 144 146 134 129
Other Operating Expenses		 3,133 3,204 3,280 3,195 3,180 3,131 3,305 3,350 3,324 3,509 3,527
Income Tax Expense		 22 39 327 170 249 653 106 404 245 308 301
Preferred Stock Dividends Declared		 32 67 33 67 34 67 32 66 31 78 31
Net Income / (Loss) Attributable to Noncontrolling Interest		 6.00 6.00 7.00 8.00 7.00 -1.00 4.00 5.00 6.00 6.00 7.00
Basic Earnings per Share		 $0.48 $0.56 $0.76 $1.11 $1.28 $1.82 $1.77 $1.29 $1.04 $1.23 $1.18
Weighted Average Basic Shares Outstanding		 752.02M 740.19M 723.02M 711.12M 700.32M 692.42M 681.23M 671.30M 665.03M 658.89M 652.05M
Diluted Earnings per Share		 $0.48 $0.56 $0.75 $1.10 $1.28 $1.81 $1.75 $1.28 $1.03 $1.22 $1.18
Weighted Average Diluted Shares Outstanding		 752.02M 740.19M 723.02M 711.12M 700.32M 692.42M 681.23M 671.30M 665.03M 658.89M 652.05M
Weighted Average Basic & Diluted Shares Outstanding		 752.02M 740.19M 723.02M 711.12M 700.32M 692.42M 681.23M 671.30M 665.03M 658.89M 652.05M

Annual Cash Flow Statements for MetLife

This table details how cash moves in and out of MetLife's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 1,944 5,125 -5,176 3,120 777 3,962 -444 79 444 -571 1,964
Net Cash From Operating Activities		 14,052 14,774 12,283 11,738 13,786 11,639 12,347 13,044 13,721 14,598 17,092
Net Cash From Continuing Operating Activities		 14,052 14,774 12,283 11,738 13,786 11,639 12,347 13,044 13,721 14,598 17,092
Net Income / (Loss) Continuing Operations		 5,385 854 4,020 5,128 5,909 5,418 6,876 5,302 1,602 4,444 3,403
Consolidated Net Income / (Loss)		 5,385 854 4,020 5,128 5,909 5,418 6,876 5,302 1,602 4,444 3,403
Depreciation Expense		 693 652 795 628 630 619 694 673 718 714 753
Amortization Expense		 -1,141 -1,110 -1,044 -1,013 -999 -816 -874 -992 -1,332 -1,512 -1,840
Non-Cash Adjustments to Reconcile Net Income		 -2,511 6,545 2,903 -1,209 821 1,565 1,321 2,615 10,627 8,804 9,161
Changes in Operating Assets and Liabilities, net		 11,626 7,833 5,609 8,204 7,425 4,853 4,330 5,446 2,106 2,148 5,615
Net Cash From Investing Activities		 -10,398 -5,850 -16,876 -5,634 -17,586 -18,569 -11,187 -2,620 -10,246 -11,493 -15,607
Net Cash From Continuing Investing Activities		 -10,398 -5,850 -16,876 -5,634 -17,586 -18,569 -11,187 -2,620 -10,246 -11,493 -15,607
Acquisitions		 -4,211 -6,963 -8,696 -4,173 -3,749 -4,247 -7,990 -7,793 -5,662 -3,981 -4,497
Purchase of Investment Securities		 -173,918 -170,240 -124,533 -125,288 -108,884 -123,132 -141,348 -116,549 -89,164 -88,213 -106,433
Sale and/or Maturity of Investments		 165,977 167,244 111,872 119,709 92,700 104,139 131,663 117,394 82,514 79,848 92,433
Other Investing Activities, net		 1,754 3,953 4,481 4,118 2,347 4,671 3,218 3,738 2,066 853 2,890
Net Cash From Financing Activities		 -1,218 -3,497 -906 -2,801 4,568 10,729 -1,126 -9,948 -2,940 -3,131 163
Net Cash From Continuing Financing Activities		 -1,218 -3,497 -906 -2,801 4,568 10,729 -1,126 -9,948 -2,940 -3,131 163
Issuance of Debt		 5,437 -3,636 4,560 224 3,526 4,812 1,912 -9,717 -612 1,609 2,157
Repayment of Debt		 -96,116 -84,610 -89,197 -90,814 -86,571 -85,498 -93,791 -98,726 -92,835 -97,749 -104,256
Repurchase of Preferred Equity		 -1,502 - - 0.00 0.00 -1,003 -500 - 0.00 0.00 -1,000
Repurchase of Common Equity		 -1,930 -372 -2,927 -3,992 -2,285 -1,151 -4,303 -3,326 -3,103 -3,207 -2,883
Payment of Dividends		 -1,769 -1,839 -1,820 -1,819 -1,821 -1,859 -1,842 -1,783 -1,764 -1,727 -1,703
Other Financing Activities, Net		 93,179 86,960 88,478 92,326 91,719 93,467 97,398 103,604 95,374 97,943 107,848
Effect of Exchange Rate Changes		 -492 -302 - -183 9.00 163 -478 -397 -91 -545 316
Cash Interest Paid		 1,178 1,202 1,118 1,130 964 891 914 905 989 1,037 1,041
Cash Income Taxes Paid		 1,127 672 1,530 1,935 1,099 787 1,102 1,056 1,833 1,600 1,564

Quarterly Cash Flow Statements for MetLife

This table details how cash moves in and out of MetLife's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Change in Cash & Equivalents		 -6,077 -3,980 14,266 -3,127 -2,544 -3,190 8,290 -3,004 -1,335 -5,512 11,815
Net Cash From Operating Activities		 3,038 3,475 5,182 2,328 3,490 4,169 4,611 4,262 2,187 3,567 7,076
Net Cash From Continuing Operating Activities		 - - 13,721 0.00 - - 14,598 0.00 - - 17,092
Net Income / (Loss) Continuing Operations		 - - 1,602 0.00 - - 4,444 0.00 - - 3,403
Net Cash From Investing Activities		 -6,346 -2,972 576 -2,627 -1,340 -2,162 -5,364 -3,322 -2,981 -5,018 -4,286
Net Cash From Continuing Investing Activities		 -6,346 -2,972 576 -2,627 -1,340 -2,162 -5,364 -3,322 -2,981 -5,018 -4,286
Acquisitions		 -1,196 -1,474 -1,446 -1,052 -1,209 -522 -1,198 -1,013 -946 -1,205 -1,333
Purchase of Investment Securities		 -25,183 -22,075 -17,084 -19,739 -22,704 -21,965 -23,805 -25,279 -23,023 -27,235 -30,896
Sale and/or Maturity of Investments		 20,677 20,007 17,923 17,941 22,268 19,585 20,054 21,710 20,253 22,802 27,668
Other Investing Activities, net		 -644 570 1,183 223 305 740 -415 1,260 735 620 275
Net Cash From Financing Activities		 379 -848 -176 -261 -1,205 -1,146 -519 220 1,449 -508 -998
Net Cash From Continuing Financing Activities		 379 -848 -176 -261 -1,205 -1,146 -519 220 1,449 -508 -998
Issuance of Debt		 -629 111 -28 850 897 -447 309 1,388 541 75 153
Repayment of Debt		 -22,827 -21,915 -20,184 -23,845 -26,462 -24,455 -22,987 -27,739 -25,198 -25,776 -25,543
Repurchase of Common Equity		 -672 -792 -859 -1,172 -855 -774 -406 -1,411 -510 -502 -460
Payment of Dividends		 -431 -459 -419 -444 -423 -450 -410 -440 -413 -444 -406
Other Financing Activities, Net		 24,938 22,207 21,314 24,350 25,638 24,980 22,975 28,422 27,029 27,139 25,258
Effect of Exchange Rate Changes		 -110 -160 145 -239 1.00 118 -425 98 197 14 7.00
Cash Interest Paid		 289 206 311 231 296 223 287 224 283 247 287
Cash Income Taxes Paid		 945 236 481 130 864 279 327 147 783 308 326

Annual Balance Sheets for MetLife

This table presents MetLife's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 877,933 898,764 719,892 687,538 740,463 795,146 759,708 663,072 687,584 677,457 745,166
Cash and Due from Banks		 12,752 12,651 12,701 15,821 16,598 19,795 20,047 20,195 20,639 20,068 22,032
Trading Account Securities		 369,747 306,380 328,189 312,321 342,264 354,809 353,685 288,132 292,500 292,427 330,748
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 3,988 3,308 3,524 3,582 3,523 17,786 3,185 3,446 3,589 3,489 3,719
Mortgage Servicing Rights		 67,102 65,167 68,731 75,752 80,529 83,919 79,353 83,763 92,506 89,012 84,593
Unearned Premiums Asset		 22,702 15,445 18,423 19,644 20,443 17,870 17,149 17,364 28,971 29,761 49,059
Deferred Acquisition Cost		 24,130 17,590 18,419 18,895 17,833 16,389 16,061 19,653 20,151 19,627 21,107
Separate Account Business Assets		 301,598 195,578 205,001 175,556 188,445 199,970 179,873 146,038 144,634 139,504 151,933
Goodwill		 9,477 9,220 9,590 9,422 9,308 10,112 9,535 9,297 9,236 8,901 9,613
Other Assets		 66,437 273,425 55,314 56,545 61,520 74,496 80,820 75,184 75,358 74,668 72,362
Total Liabilities & Shareholders' Equity		 877,933 898,764 719,892 687,538 740,463 795,146 759,708 663,072 687,584 677,457 745,166
Total Liabilities		 809,437 831,062 661,022 634,580 674,081 720,329 691,959 632,947 657,331 649,754 716,245
Short-Term Debt		 36,971 26,115 26,511 25,503 40,809 29,997 32,261 35,759 17,643 32,679 31,937
Long-Term Debt		 25,356 20,884 19,951 17,036 4,143 18,601 17,855 3,874 19,346 3,640 5,713
Future Policy Benefits		 191,879 166,636 177,974 186,780 194,909 206,656 199,721 187,222 196,406 193,646 208,855
Participating Policy Holder Equity		 219,480 188,515 200,836 201,327 212,499 225,833 223,384 229,408 219,655 240,729 257,283
Separate Account Business Liabilities		 301,598 195,578 205,001 175,556 188,445 199,970 179,873 146,038 144,634 139,504 151,933
Other Long-Term Liabilities		 34,153 233,334 30,749 28,378 33,276 39,272 38,865 30,646 59,647 39,556 60,524
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 77 - - - - - - - - 0.00 241
Total Equity & Noncontrolling Interests		 68,419 67,702 58,870 52,958 66,382 74,817 67,749 30,125 30,253 27,703 28,680
Total Preferred & Common Equity		 67,949 67,531 58,676 52,741 66,144 74,558 67,482 29,881 30,015 27,445 28,398
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 67,949 67,531 58,676 52,741 66,144 74,558 67,482 29,881 30,015 27,445 28,398
Common Stock		 30,761 30,956 31,123 32,486 32,692 33,824 33,523 33,628 33,702 33,803 32,870
Retained Earnings		 35,519 34,683 26,527 28,926 33,078 36,491 41,197 40,332 40,146 42,626 44,290
Treasury Stock		 -3,102 -3,474 -6,401 -10,393 -12,678 -13,829 -18,157 -21,458 -24,591 -27,798 -30,678
Accumulated Other Comprehensive Income / (Loss)		 4,771 5,366 7,427 1,722 13,052 18,072 10,919 -22,621 -19,242 -21,186 -18,084
Noncontrolling Interest		 470 171 194 217 238 259 267 244 238 258 282

Quarterly Balance Sheets for MetLife

This table presents MetLife's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets		 674,266 677,279 652,120 687,584 677,576 675,745 704,976 677,457 688,316 702,470 719,726
Cash and Due from Banks		 18,456 15,417 14,912 20,639 19,840 20,786 21,765 20,068 21,326 22,178 20,233
Trading Account Securities		 295,612 294,830 281,404 292,500 289,472 288,596 293,779 292,427 303,207 311,221 317,703
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 3,554 3,505 3,704 3,589 3,636 3,657 13,757 3,489 3,557 3,532 3,791
Mortgage Servicing Rights		 85,572 92,986 92,230 92,506 91,458 89,802 90,415 89,012 87,908 86,868 85,843
Unearned Premiums Asset		 18,692 18,530 19,002 28,971 29,986 31,820 31,443 29,761 31,251 31,503 40,329
Deferred Acquisition Cost		 19,976 19,850 19,737 20,151 19,842 19,568 20,401 19,627 20,162 20,993 21,175
Separate Account Business Assets		 148,417 145,946 135,624 144,634 141,003 139,707 148,809 139,504 138,143 143,175 146,344
Goodwill		 9,379 9,261 9,109 9,236 9,037 8,950 9,155 8,901 9,036 9,142 9,095
Other Assets		 74,608 76,954 76,398 75,358 73,302 72,859 75,452 74,668 73,726 73,858 75,213
Total Liabilities & Shareholders' Equity		 674,266 677,279 652,120 687,584 677,576 675,745 704,976 677,457 688,316 702,470 719,726
Total Liabilities		 641,843 646,787 626,225 657,331 648,780 648,205 673,812 649,754 660,561 674,543 690,535
Short-Term Debt		 34,653 33,545 33,492 17,643 33,569 18,109 17,536 32,679 17,821 32,900 32,817
Long-Term Debt		 3,863 3,835 3,811 19,346 3,752 18,527 18,970 3,640 19,311 4,591 4,552
Future Policy Benefits		 191,741 190,474 181,755 196,406 191,013 190,993 201,340 193,646 197,667 198,965 199,169
Participating Policy Holder Equity		 232,523 234,421 233,979 219,655 239,744 239,287 244,922 240,729 225,979 252,699 256,042
Separate Account Business Liabilities		 148,417 145,946 135,624 144,634 141,003 139,707 148,809 139,504 138,143 143,175 146,344
Other Long-Term Liabilities		 30,646 38,566 37,564 59,647 39,699 41,582 42,235 39,556 61,640 42,213 51,611
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 32,423 30,492 25,895 30,253 28,796 27,540 31,164 27,703 27,755 27,927 29,191
Total Preferred & Common Equity		 32,194 30,261 25,658 30,015 28,535 27,252 30,885 27,445 27,493 27,685 28,944
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 32,194 30,261 25,658 30,015 28,535 27,252 30,885 27,445 27,493 27,685 28,944
Common Stock		 33,629 33,642 33,678 33,702 33,730 33,752 33,778 33,803 33,832 33,834 32,867
Retained Earnings		 39,957 39,928 39,958 40,146 40,350 40,873 41,765 42,626 43,131 43,447 43,887
Treasury Stock		 -22,245 -22,923 -23,724 -24,591 -25,774 -26,637 -27,418 -27,798 -29,222 -29,737 -30,244
Accumulated Other Comprehensive Income / (Loss)		 -19,147 -20,386 -24,254 -19,242 -19,771 -20,736 -17,240 -21,186 -20,248 -19,859 -17,566
Noncontrolling Interest		 229 231 237 238 261 288 279 258 262 242 247

Annual Metrics And Ratios for MetLife

This table displays calculated financial ratios and metrics derived from MetLife's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - - - - 658,891,656.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 658,891,656.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 5.16
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $6.10 $5.72 $7.36 $2.93 $1.82 $5.98 $4.74
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 0.00 915.83M 884.40M 825.08M 774.36M 723.02M 681.23M 652.05M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $6.06 $5.68 $7.31 $2.91 $1.81 $5.94 $4.71
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 915.83M 884.40M 825.08M 774.36M 723.02M 681.23M 652.05M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 915.83M 884.40M 825.08M 774.36M 723.02M 681.23M 652.05M
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for MetLife

This table displays calculated financial ratios and metrics derived from MetLife's official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
DEI Shares Outstanding		 - - - - - - - - - - 658,891,656.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 658,891,656.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 1.24
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.48 $0.56 $0.76 $1.11 $1.28 $1.82 $1.77 $1.29 $1.04 $1.23 $1.18
Adjusted Weighted Average Basic Shares Outstanding		 752.02M 740.19M 723.02M 711.12M 700.32M 692.42M 681.23M 671.30M 665.03M 658.89M 652.05M
Adjusted Diluted Earnings per Share		 $0.48 $0.56 $0.75 $1.10 $1.28 $1.81 $1.75 $1.28 $1.03 $1.22 $1.18
Adjusted Weighted Average Diluted Shares Outstanding		 752.02M 740.19M 723.02M 711.12M 700.32M 692.42M 681.23M 671.30M 665.03M 658.89M 652.05M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 752.02M 740.19M 723.02M 711.12M 700.32M 692.42M 681.23M 671.30M 665.03M 658.89M 652.05M
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Financials Breakdown Chart

Key Financial Trends

Below is a concise, investor-focused view of MetLife (MET) using the last four years of quarterly statements provided. The highlights focus on cash flow, income, and balance-sheet trends that may impact the stock over time.

  • Total Revenue in Q4 2025 rose to $24.045 billion, supported by a strong Premiums Earned line of $16.691 billion and notable capital gains within non-interest income.
  • Premiums Earned in Q4 2025 were $16.691 billion, indicating solid policy sales/renewals contributing to topline strength.
  • Net Cash From Continuing Operating Activities in Q4 2025 was $17.092 billion, marking a robust quarter for cash generation from core operations.
  • MET repaid substantial debt in 2025, with roughly $25.8 billion repaid in Q3 2025 and about $25.5 billion repaid in Q4 2025, improving leverage and the interest outlook.
  • Share repurchases totaled about $0.96 billion in 2025 (Q3: $0.50B; Q4: $0.46B), signaling ongoing capital return to shareholders.
  • Total assets grew to about $719.7 billion by Q3 2025, reflecting continued scale and investment capacity to support policyholder liabilities.
  • Non-interest income benefited from net realized and unrealized capital gains on investments in Q4 2025 (about $5.12 billion), reflecting favorable market conditions but exposing results to market volatility.
  • Earnings per share remained broadly stable around $1.18 (basic and diluted) in Q4 2025, suggesting solid profitability despite quarterly fluctuations.
  • Total liabilities stayed very large, around $690 billion by Q3 2025, underscoring substantial actuarial obligations (e.g., Future Policy Benefits) and a high leverage base.
  • Cash flow has shown quarterly volatility, with Q3 2025 producing a negative net change in cash before a strong Q4 2025 swing, signaling liquidity sensitivity to financing and investing activities.
05/06/26 02:50 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About MetLife's Financials

When does MetLife's fiscal year end?

According to the most recent income statement we have on file, MetLife's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has MetLife's net income changed over the last 10 years?

In the past 10 years, MetLife's net income has ranged from $854 million in 2016 to $6.88 billion in 2021, and is currently $3.40 billion as of their latest financial filing in 2025. Check out MetLife's forecast to explore projected trends and price targets.

How has MetLife's revenue changed over the last 10 years?

Over the last 10 years, MetLife's total revenue changed from $61.34 billion in 2015 to $77.59 billion in 2025, a change of 26.5%.

How much debt does MetLife have?

MetLife's total liabilities were at $716.25 billion at the end of 2025, a 10.2% increase from 2024, and a 11.5% decrease since 2015.

How much cash does MetLife have?

In the past 10 years, MetLife's cash and equivalents has ranged from $12.65 billion in 2016 to $22.03 billion in 2025, and is currently $22.03 billion as of their latest financial filing in 2025.


Related Companies

Financial statements for NYSE:MET last updated on 2/22/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Why U.S. Bank CEOs Are Panicking Right Now
Why U.S. Bank CEOs Are Panicking Right Now Treasury Secretary Bessent and Fed Chair Powell recently summone...
Chaikin Analytics | Sponsoredtc pixel
The Iran War Just Broke the Gold Market
The Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged...
Behind the Markets | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Trump and Elon are BACK
15X Bigger Than SpaceX: Elon's New Launch While the rest of the market goes crazy for "the mother of all IP...
InvestorPlace | Sponsoredtc pixel
Military ‘Dark Energy’ to Power AI
When it was put inside U.S. tanks, they moved almost silently and produced no smoke. Now, Elon Musk is using t...
Altimetry | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel